Urinary orosomucoid a potential marker of inflammation in Psoriasis

Péter Kustán, T. Kőszegi, A. Miseta, Iván Péter, Zénó Ajtay, István Kiss, Balázs Németh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Psoriasis is one of the most common chronic, life-long dermatologic diseases, which has considerable negative effects on quality of life. Psoriasis is considered as a systemic inflammatory disease, thus acute phase proteins such as C-reactive protein (CRP) and orosomucoid (ORM) have been shown to play a role in its pathophysiology. This study was aimed to compare CRP, serum ORM (se-ORM) and urinary ORM (u-ORM) levels of psoriatic patients to healthy individuals. Methods: 87 psoriatic patients and 41 healthy individuals were enrolled. Simultaneously obtained venous blood and spot urine samples were analysed. High sensitivity CRP and se-ORM levels were determined by routine procedures on automated analyzers. Urinary ORM was measured by a novel automated turbidimetric assay. U-ORM was referred to urinary creatinine (u-ORM/u-CREAT, mg/mmol). Results: Significantly higher hsCRP (p<0.001) and u-ORM/u-CREAT (p=0.001) levels were found among psoriatic patients compared to controls. No significant differences were found between the groups regarding se-ORM levels. HsCRP, se-ORM and u-ORM/u-CREAT levels were significantly higher in patients with severe psoriasis than in mild and moderate cases (p<0.05). Conclusion: As a highly sensitive, easily available biomarker u-ORM shows itself capable of becoming a new inflammatory marker in psoriasis providing clinically useful information on disease severity.

Original languageEnglish
Pages (from-to)1113-1117
Number of pages5
JournalInternational Journal of Medical Sciences
Volume15
Issue number11
DOIs
Publication statusPublished - Jul 13 2018

Fingerprint

Orosomucoid
Psoriasis
Inflammation
C-Reactive Protein
Serum
Acute-Phase Proteins
Creatinine
Biomarkers
Quality of Life
Urine

Keywords

  • Biomarker
  • Inflammation
  • Orosomucoid
  • Psoriasis
  • Urine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Urinary orosomucoid a potential marker of inflammation in Psoriasis. / Kustán, Péter; Kőszegi, T.; Miseta, A.; Péter, Iván; Ajtay, Zénó; Kiss, István; Németh, Balázs.

In: International Journal of Medical Sciences, Vol. 15, No. 11, 13.07.2018, p. 1113-1117.

Research output: Contribution to journalArticle

Kustán, Péter ; Kőszegi, T. ; Miseta, A. ; Péter, Iván ; Ajtay, Zénó ; Kiss, István ; Németh, Balázs. / Urinary orosomucoid a potential marker of inflammation in Psoriasis. In: International Journal of Medical Sciences. 2018 ; Vol. 15, No. 11. pp. 1113-1117.
@article{a68241d2dcc449e3be6900e54bfa68e2,
title = "Urinary orosomucoid a potential marker of inflammation in Psoriasis",
abstract = "Background: Psoriasis is one of the most common chronic, life-long dermatologic diseases, which has considerable negative effects on quality of life. Psoriasis is considered as a systemic inflammatory disease, thus acute phase proteins such as C-reactive protein (CRP) and orosomucoid (ORM) have been shown to play a role in its pathophysiology. This study was aimed to compare CRP, serum ORM (se-ORM) and urinary ORM (u-ORM) levels of psoriatic patients to healthy individuals. Methods: 87 psoriatic patients and 41 healthy individuals were enrolled. Simultaneously obtained venous blood and spot urine samples were analysed. High sensitivity CRP and se-ORM levels were determined by routine procedures on automated analyzers. Urinary ORM was measured by a novel automated turbidimetric assay. U-ORM was referred to urinary creatinine (u-ORM/u-CREAT, mg/mmol). Results: Significantly higher hsCRP (p<0.001) and u-ORM/u-CREAT (p=0.001) levels were found among psoriatic patients compared to controls. No significant differences were found between the groups regarding se-ORM levels. HsCRP, se-ORM and u-ORM/u-CREAT levels were significantly higher in patients with severe psoriasis than in mild and moderate cases (p<0.05). Conclusion: As a highly sensitive, easily available biomarker u-ORM shows itself capable of becoming a new inflammatory marker in psoriasis providing clinically useful information on disease severity.",
keywords = "Biomarker, Inflammation, Orosomucoid, Psoriasis, Urine",
author = "P{\'e}ter Kust{\'a}n and T. Kőszegi and A. Miseta and Iv{\'a}n P{\'e}ter and Z{\'e}n{\'o} Ajtay and Istv{\'a}n Kiss and Bal{\'a}zs N{\'e}meth",
year = "2018",
month = "7",
day = "13",
doi = "10.7150/ijms.25687",
language = "English",
volume = "15",
pages = "1113--1117",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "11",

}

TY - JOUR

T1 - Urinary orosomucoid a potential marker of inflammation in Psoriasis

AU - Kustán, Péter

AU - Kőszegi, T.

AU - Miseta, A.

AU - Péter, Iván

AU - Ajtay, Zénó

AU - Kiss, István

AU - Németh, Balázs

PY - 2018/7/13

Y1 - 2018/7/13

N2 - Background: Psoriasis is one of the most common chronic, life-long dermatologic diseases, which has considerable negative effects on quality of life. Psoriasis is considered as a systemic inflammatory disease, thus acute phase proteins such as C-reactive protein (CRP) and orosomucoid (ORM) have been shown to play a role in its pathophysiology. This study was aimed to compare CRP, serum ORM (se-ORM) and urinary ORM (u-ORM) levels of psoriatic patients to healthy individuals. Methods: 87 psoriatic patients and 41 healthy individuals were enrolled. Simultaneously obtained venous blood and spot urine samples were analysed. High sensitivity CRP and se-ORM levels were determined by routine procedures on automated analyzers. Urinary ORM was measured by a novel automated turbidimetric assay. U-ORM was referred to urinary creatinine (u-ORM/u-CREAT, mg/mmol). Results: Significantly higher hsCRP (p<0.001) and u-ORM/u-CREAT (p=0.001) levels were found among psoriatic patients compared to controls. No significant differences were found between the groups regarding se-ORM levels. HsCRP, se-ORM and u-ORM/u-CREAT levels were significantly higher in patients with severe psoriasis than in mild and moderate cases (p<0.05). Conclusion: As a highly sensitive, easily available biomarker u-ORM shows itself capable of becoming a new inflammatory marker in psoriasis providing clinically useful information on disease severity.

AB - Background: Psoriasis is one of the most common chronic, life-long dermatologic diseases, which has considerable negative effects on quality of life. Psoriasis is considered as a systemic inflammatory disease, thus acute phase proteins such as C-reactive protein (CRP) and orosomucoid (ORM) have been shown to play a role in its pathophysiology. This study was aimed to compare CRP, serum ORM (se-ORM) and urinary ORM (u-ORM) levels of psoriatic patients to healthy individuals. Methods: 87 psoriatic patients and 41 healthy individuals were enrolled. Simultaneously obtained venous blood and spot urine samples were analysed. High sensitivity CRP and se-ORM levels were determined by routine procedures on automated analyzers. Urinary ORM was measured by a novel automated turbidimetric assay. U-ORM was referred to urinary creatinine (u-ORM/u-CREAT, mg/mmol). Results: Significantly higher hsCRP (p<0.001) and u-ORM/u-CREAT (p=0.001) levels were found among psoriatic patients compared to controls. No significant differences were found between the groups regarding se-ORM levels. HsCRP, se-ORM and u-ORM/u-CREAT levels were significantly higher in patients with severe psoriasis than in mild and moderate cases (p<0.05). Conclusion: As a highly sensitive, easily available biomarker u-ORM shows itself capable of becoming a new inflammatory marker in psoriasis providing clinically useful information on disease severity.

KW - Biomarker

KW - Inflammation

KW - Orosomucoid

KW - Psoriasis

KW - Urine

UR - http://www.scopus.com/inward/record.url?scp=85051130076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051130076&partnerID=8YFLogxK

U2 - 10.7150/ijms.25687

DO - 10.7150/ijms.25687

M3 - Article

C2 - 30123048

AN - SCOPUS:85051130076

VL - 15

SP - 1113

EP - 1117

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 11

ER -